Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Umbilical cord blood transplantation may allow doctors to give higher doses of
chemotherapy or radiation therapy and kill more cancer cells.
PURPOSE: This phase II trial is studying allogeneic umbilical cord blood transplantation to
see how well it works when given with chemotherapy or radiation therapy in treating patients
with high-risk hematologic cancer.